Rationale and Design of Neuro-Ttransform, a Phase 3 Study to Evaluate the Efficacy and Safety of Akcea-Ttr-Lrx (Ion-682884) in Patients with Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
AuthID
P-00S-KP3
P-00S-KP3